GlaxoSmithKline India in deal with Japanese Daiichi

New Delhi, May 14 (UNI) Pharma giant GlaxoSmithKline Pharmaceuticals Ltd today said it has signed a co-production agreement with Japanese drugmaker Daiichi Sankyo.

The company has signed a co-production agreement with Japanese drug maker Daiichi Sankyo for anti-hypertensive drug Olmesartan Medoxomil and its combination products, the company said in a statement.

However, the company refused to disclose any financial details.

UNI AK PDT DS1235